Treatment of polyarteritis nodosa and microscopic polyangiitis

Arthritis and Rheumatism

Volumn 41, Issue 12, 1998, Pages 2100-2105

  Guillevin, Loïc ^a   Lhote, François ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISONE; STEROID;

HISTORY; HUMAN; IMMUNOTHERAPY; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; STEROID THERAPY;

HUMANS; POLYARTERITIS NODOSA; VASCULITIS, HYPERSENSITIVITY;

EID: 0032434130     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199812)41:12<2100::AID-ART3>3.0.CO;2-J     Document Type: Review

References (15)

1. Küssmaul A, Maier K. Ueber eine nicht bisher beschreibene eigentümliche Arterienerkrankung (Periarteritis Nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskelhämung einhergeht. Dtsch Arch Klin Med 1866;1:484-518.
2. Wohlwill F. Uber die nur Mikroskopisch erkenbarre Form der Periarteritis nodosa. Arch Pathol Anat 1923;246:377-411.
3. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. QJM 1948;17:175-202.
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an International Consensus Conference. Arthritis Rheum 1994;37:187-92.
5. Bagenstoss A, Shick R, Polley H. The effect of cortisone on the lesions of periarteritis nodosa. Am J Pathol 1950;26:709.
6. Frohnert P, Sheps S. Long term follow-up study of polyarteritis nodosa. Am J Med 1967;48:8-14.
7. Leib E, Restivo C, Paulus H. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 1979;67:941-7.
8. Cohen R, Conn D, Ilstrup D. Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 1980;55:146-55.
9. Fauci A, Katz P, Haynes B, Wolff S. Cyclophosphamide therapy of severe necrotizing vasculitis. N Engl J Med 1979;301:235-8.
10. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995;74:238-53.
11. Calabrese LH. Vasculitis and infection with the human immunodeficiency virus. Rheum Dis Clin North Am 1991;17:131-47.
12. Guillevin L, Lhote F, Jarrousse B, Fain O. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: a meta-analysis of 3 prospective controlled trials including 182 patients over 12 years. Ann Med Interne (Paris) 1992;143:405-16.
13. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28.
14. Luqmani R, Exley A, Kitas G, Bacon P. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997;11:423-46.
15. Rasmussen N, Jayne DRW, Abramowicz D, Andrassy K, Bacon PA, Cohen-Terwaert JW, et al. European therapeutic trials in ANCA-associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immunol 1995;101:29-34.